Related Experiment Video
Updated: Mar 30, 2026

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development?
1Cellular and Molecular Signaling, Newark, New Jersey 07101, USA.
Abstract:
Small non-coding ribonucleic acids (RNAs), known as microRNAs (miRNAs), are now becoming recognized as significant agents that can affect the onset and progression of numerous disorders throughout the body. In particular, miRNAs also may determine stem cell renewal and differentiation. Intimately tied to the ability of miRNAs to govern stem cell proliferation are the proliferative pathways of silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1) and the cell survival mechanisms of autophagy that can be coupled to the activity of the mechanistic target of rapamycin (mTOR). Targeting miRNAs that oversee SIRT1 activity offers interesting prospects for the translation of these pathways into efficacious clinical treatment programs for a host of disorders. Yet, as work in this area progresses, a number of challenges unfold that impact whether manipulation of non-coding RNAs and SIRT1 can finely guide stem cell renewal and differentiation to reach successful clinical outcomes.
Insights
MicroRNAs regulate stem cell renewal and differentiation by influencing SIRT1 and autophagy pathways. Targeting these microRNAs shows therapeutic potential but faces challenges for clinical application.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Genetics
Background:
- Small non-coding RNAs, microRNAs (miRNAs), are key regulators of cellular processes.
- miRNAs influence stem cell renewal, differentiation, and disease progression.
- SIRT1 and mTOR-autophagy pathways are critical for stem cell proliferation and survival.
Purpose of the Study:
- To explore the role of miRNAs in regulating stem cell renewal and differentiation.
- To investigate the interplay between miRNAs, SIRT1, and mTOR-mediated autophagy.
- To assess the therapeutic potential and challenges of targeting miRNAs for clinical applications.
Main Methods:
- Review of current literature on miRNA function in stem cells.
- Analysis of the molecular mechanisms linking miRNAs to SIRT1 and autophagy.
- Discussion of translational challenges in manipulating non-coding RNAs for therapeutic benefit.
Main Results:
- miRNAs significantly impact stem cell fate decisions.
- miRNA regulation of SIRT1 and mTOR-autophagy pathways is crucial for stem cell behavior.
- Targeting specific miRNAs offers potential for treating various disorders.
Conclusions:
- miRNAs are critical regulators of stem cell renewal and differentiation.
- The interplay between miRNAs, SIRT1, and autophagy presents therapeutic opportunities.
- Overcoming challenges in miRNA-based therapies is essential for successful clinical translation.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tissue Renewal without Stem Cells
However, failure of such a system...
iPS Cell Differentiation

